Desq Long
Sign in

Company

BeOne Medicines Ltd.

ONC · CIK 0001651308

SEC FORM 4
$407,897.32

BeOne Medicines Ltd. (ONC)

Sale of 1,181 shares at $345.383 per share.

Reporting Person Wang Xiaodong · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$983,433.46

BeOne Medicines Ltd. (ONC)

Sale of 2,841 shares at $346.1575 per share.

Reporting Person Wang Xiaodong · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$526,992.91

BeOne Medicines Ltd. (ONC)

Sale of 1,517 shares at $347.3915 per share.

Reporting Person Wang Xiaodong · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$598,929.68

BeOne Medicines Ltd. (ONC)

Sale of 1,721 shares at $348.0126 per share.

Reporting Person Wang Xiaodong · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$1,144,896.30

BeOne Medicines Ltd. (ONC)

Acquisition (code M) of 31,027 shares at $36.90 per share.

Reporting Person Wang Xiaodong · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$2,609,572.98

BeOne Medicines Ltd. (ONC)

Sale of 7,492 shares at $348.3146 per share.

Reporting Person Wang Xiaodong · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$3,733,140.98

BeOne Medicines Ltd. (ONC)

Sale of 10,688 shares at $349.2834 per share.

Reporting Person Wang Xiaodong · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$2,300,950.56

BeOne Medicines Ltd. (ONC)

Sale of 6,569 shares at $350.2741 per share.

Reporting Person Wang Xiaodong · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$2,205,173.87

BeOne Medicines Ltd. (ONC)

Sale of 6,278 shares at $351.2542 per share.

Reporting Person Wang Xiaodong · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001662982-26-000002 · filed 2026-09-10 · View filing →

SEC FORM 4
$46,973.52

BeOne Medicines Ltd. (ONC)

Sale of 132 shares at $355.86 per share.

Reporting Person Ball Titus B. · Officer Title Principal Accounting Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001675628-26-000003 · filed 2026-09-03 · View filing →

SEC FORM 4
$106,400.00

BeOne Medicines Ltd. (ONC)

Sale of 280 shares at $380 per share.

Reporting Person Wu Xiaobin · Officer Title President and COO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001739452-26-000011 · filed 2026-08-27 · View filing →

SEC FORM 4
$157,909.64

BeOne Medicines Ltd. (ONC)

Acquisition (code M) of 812 shares at $194.47 per share.

Reporting Person Lee Chan Henry · Officer Title SVP, General Counsel · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001980648-26-000024 · filed 2026-08-13 · View filing →

SEC FORM 4
$225,692.56

BeOne Medicines Ltd. (ONC)

Acquisition (code M) of 1,058 shares at $213.32 per share.

Reporting Person Lee Chan Henry · Officer Title SVP, General Counsel · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001980648-26-000024 · filed 2026-08-13 · View filing →

SEC FORM 4
$126,587.88

BeOne Medicines Ltd. (ONC)

Acquisition (code M) of 796 shares at $159.03 per share.

Reporting Person Lee Chan Henry · Officer Title SVP, General Counsel · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001980648-26-000024 · filed 2026-08-13 · View filing →

SEC FORM 4
$959,760.00

BeOne Medicines Ltd. (ONC)

Sale of 2,666 shares at $360 per share.

Reporting Person Lee Chan Henry · Officer Title SVP, General Counsel · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001980648-26-000024 · filed 2026-08-13 · View filing →

SEC FORM 4
$702,320.26

BeOne Medicines Ltd. (ONC)

Sale of 1,980 shares at $354.7072 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$896,425.98

BeOne Medicines Ltd. (ONC)

Sale of 2,515 shares at $356.4318 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$5,506,146.92

BeOne Medicines Ltd. (ONC)

Sale of 15,396 shares at $357.6349 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$7,490,448.21

BeOne Medicines Ltd. (ONC)

Sale of 20,899 shares at $358.4118 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$5,064,252.42

BeOne Medicines Ltd. (ONC)

Sale of 14,102 shares at $359.1159 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$4,920,843.58

BeOne Medicines Ltd. (ONC)

Sale of 13,695 shares at $359.3168 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$2,911,849.36

BeOne Medicines Ltd. (ONC)

Sale of 8,081 shares at $360.3328 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$5,266,268.09

BeOne Medicines Ltd. (ONC)

Sale of 14,569 shares at $361.4708 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$4,191,547.96

BeOne Medicines Ltd. (ONC)

Sale of 11,568 shares at $362.3399 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$4,871,344.48

BeOne Medicines Ltd. (ONC)

Sale of 13,403 shares at $363.4518 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,898,442.34

BeOne Medicines Ltd. (ONC)

Sale of 5,211 shares at $364.3144 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,160,079.10

BeOne Medicines Ltd. (ONC)

Sale of 3,176 shares at $365.2642 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$439,574.40

BeOne Medicines Ltd. (ONC)

Sale of 1,200 shares at $366.312 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,468.00

BeOne Medicines Ltd. (ONC)

Sale of 4 shares at $367 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$23,450.00

BeOne Medicines Ltd. (ONC)

Sale of 67 shares at $350 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,327,130.18

BeOne Medicines Ltd. (ONC)

Sale of 3,680 shares at $360.6332 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$989,602.71

BeOne Medicines Ltd. (ONC)

Sale of 2,813 shares at $351.7962 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,297,741.05

BeOne Medicines Ltd. (ONC)

Sale of 3,673 shares at $353.3191 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$2,383,028.38

BeOne Medicines Ltd. (ONC)

Sale of 6,717 shares at $354.7757 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,236,261.30

BeOne Medicines Ltd. (ONC)

Sale of 3,476 shares at $355.6563 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$4,428,482.32

BeOne Medicines Ltd. (ONC)

Sale of 12,418 shares at $356.618 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$5,675,863.64

BeOne Medicines Ltd. (ONC)

Sale of 15,869 shares at $357.6699 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$16,157,075.60

BeOne Medicines Ltd. (ONC)

Sale of 45,044 shares at $358.6954 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →

SEC FORM 4
$7,640,825.75

BeOne Medicines Ltd. (ONC)

Sale of 21,254 shares at $359.5006 per share.

Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →